Successful autologous peripheral blood stem cell transplantation with a double-conditioning regimen for recurrent hepatoblastoma after liver transplantation

Pediatric Transplantation

Volumn 13, Issue 2, 2009, Pages 259-262

  Niwa, Akira ^a   Umeda, Katsutsugu ^a   Awaya, Tomonari ^a   Yui, Yoshihiro ^a   Matsubara, Hiroshi ^a   Hiramatsu, Hidefumi ^a   Watanabe, Ken Ichiro ^a   Adachi, Souichi ^a   Itoh, Takashi ^a   Uemoto, Shinji ^a   Nakahata, Tatsutoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Double conditioning regimen; Hepatoblastoma; High dose chemotherapy; Liver transplantation

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; MELPHALAN; METHYLPREDNISOLONE; PIRARUBICIN; TACROLIMUS; THIOTEPA;

ABSENCE OF SIDE EFFECTS; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; CHILD; DRUG WITHDRAWAL; ENGRAFTMENT; GRAFT REJECTION; HEPATOBLASTOMA; HUMAN; LIVER DYSFUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD;

ANTINEOPLASTIC AGENTS; CHILD, PRESCHOOL; GRAFT REJECTION; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; RECURRENCE; TACROLIMUS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 59449085095     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00948.x     Document Type: Article

References (11)

1. von Schweinitz D, Byrd DJ, Hecker H, et al. Efficiency and toxicity of ifosfamide, cisplatin, and doxorubicin in the treatment of childhood hepatoblastoma. Eur J Cancer 1997 : 33 : 1243 1249.
2. Carceller A, Blanchradh H, Champagne J, et al. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma. J Pediatr Sur 2001 : 36 : 755 759.
3. Otte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) Study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004 : 42 : 74 83.
4. Kasahara M, Ueda M, Haga H, et al. Living-donor liver transplantation for hepatoblastoma. Am J Transplant 2005 : 5 : 2229 2235.
5. Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study. J Clin Oncol 2005 : 23 : 1245 1252.
6. Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treated the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Tumor. J Pediatr Surg 2002 : 37 : 851 856.
7. Hara J, Osugi Y, Ohta H, et al. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors. Bone Marrow Transplant 1998 : 22 : 7 12.
8. Yoshinari M, Imaizumi M, Hayashi Y, et al. Peripheral blood stem cell transplantation for hepatoblastoma with microscopic residue: A therapeutic approach for incompletely resected tumor. Tohoku Exp Med 1998 : 184 : 247 254.
9. Nishimura SI, Sato T, Fujita N, et al. High-dose chemotherapy in children with metastatic hepatoblastoma. Pediatr Int 2002 : 44 : 300 305.
10. Chiang KY, Lazarus HM. Should we be performing more combined hematopoietic stem cell plus solid organ transplants? Bone Marrow Transplant 2003 : 31 : 633 642.
11. Umeda K, Adachi S, Watanabe K, et al. Successful hematopoietic stem cell transplantation for aplastic anemia following living related liver transplantation. Bone Marrow Transplant 2002 : 30 : 531 534.